The bill aims to enhance access to human immunodeficiency virus (HIV) postexposure prophylaxis (PEP) drugs and therapies in Washington State. It mandates that hospitals adopt policies aligned with CDC guidelines for dispensing PEP medications, ensuring that patients receive a 28-day supply following potential HIV exposure, unless contraindicated. Additionally, the bill allows practitioners to prescribe prepackaged emergency medications, including PEP, to patients being discharged from emergency departments when community pharmacy services are unavailable. It also establishes reimbursement protocols for hospitals providing these medications.

Furthermore, the bill prohibits health carriers from imposing cost-sharing or prior authorization for PEP drugs in certain health plans starting January 1, 2025, and requires Medicaid managed care organizations to provide similar coverage without prior authorization. It ensures that hospitals are reimbursed separately for PEP drugs dispensed in emergency departments, distinct from bundled payments for other services. The bill includes various amendments to existing laws to incorporate these provisions and is set to take effect on January 1, 2025.

Statutes affected:
Original Bill: 70.41.480
Substitute Bill: 70.41.480
Engrossed Substitute: 70.41.480
Bill as Passed Legislature: 70.41.480
Session Law: 70.41.480